Palacios IF
Massachusetts General Hospital, 70 Blossom St., Boston MA, 02114, USA.
Curr Treat Options Cardiovasc Med. 1999 Jun;1(1):79-89. doi: 10.1007/s11936-999-0010-z.
Pericardial effusion may occur as a result of a variety of clinical conditions, including viral, bacterial, or fungal infections and inflammatory, postinflammatory, autoreactive, and neoplastic processes. More common causes of pericardial effusion and tamponade include malignancy, renal failure, viral and bacterial infectious processes, radiation, aortic dissection, and hypothyroidism. It can also occur after trauma or acute myocardial infarction (as in postpericardiotomy syndrome following cardiac or thoracic surgery) or as an idiopathic pericardial effusion. Although pericardial effusion is common in patients with connective tissue disease, cardiac tamponade is rare. Among medical patients, malignant disease is the most common cause of pericardial effusion with tamponade. Table 1 shows the causes of pericardial tamponade. The effusion fluid may be serous, suppurative, hemorrhagic, or serosanguineous. The pericardial fluid can be a transudate (typically occurring in patients with congestive heart failure) or an exudate. The latter type, which contains a high concentration of proteins and fibrin, can occur with any type of pericarditis, severe infections, or malignancy. Once the diagnosis of pericardial effusion has been made, it is important to determine whether the effusion is creating significant hemodynamic compromise. Asymptomatic patients without hemodynamic compromise, even with large pericardial effusions, do not need to be treated with pericardiocentesis unless there is a need for fluid analysis for diagnostic purposes (eg, in acute bacterial pericarditis, tuberculosis, and neoplasias). The diagnosis of pericardial effusion/tamponade relies on a strong clinical suspicion and is confirmed by echocardiography or other pericardial imaging modalities. Alternatively, when the diagnosis of cardiac tamponade is made, there is a need for emergency drainage of pericardial fluid by pericardiocentesis or surgery to relieve the hemodynamic compromise. Following pericardiocentesis, it is necessary to prevent recurrence of tamponade. Intrapericardial injection of sclerosing agents, surgical pericardiotomy, and percutaneous balloon pericardial window creation are techniques used to prevent reaccumulation of pericardial fluid and recurrence of cardiac tamponade.
心包积液可能由于多种临床情况而发生,包括病毒、细菌或真菌感染以及炎症、炎症后、自身反应性和肿瘤性过程。心包积液和心脏压塞更常见的原因包括恶性肿瘤、肾衰竭、病毒和细菌感染过程、放疗、主动脉夹层和甲状腺功能减退。它也可能发生在创伤或急性心肌梗死后(如心脏或胸外科手术后的心包切开术后综合征)或作为特发性心包积液。虽然心包积液在结缔组织病患者中很常见,但心脏压塞很少见。在内科患者中,恶性疾病是心包积液合并心脏压塞最常见的原因。表1显示了心脏压塞的原因。积液可能是浆液性、脓性、血性或浆液血性的。心包液可以是漏出液(通常发生在充血性心力衰竭患者中)或渗出液。后一种类型含有高浓度的蛋白质和纤维蛋白,可发生于任何类型的心包炎、严重感染或恶性肿瘤。一旦诊断出心包积液,确定积液是否造成显著的血流动力学损害很重要。无症状且无血流动力学损害的患者,即使有心包大量积液,除非需要进行液体分析以明确诊断(如急性细菌性心包炎、结核病和肿瘤),否则无需进行心包穿刺治疗。心包积液/心脏压塞的诊断依赖于强烈的临床怀疑,并通过超声心动图或其他心包成像方式得以证实。另外,当诊断为心脏压塞时,需要通过心包穿刺或手术紧急引流心包液以缓解血流动力学损害。心包穿刺后,有必要防止心脏压塞复发。心包内注射硬化剂、外科心包切开术和经皮球囊心包开窗术是用于防止心包液再次积聚和心脏压塞复发的技术。